The Cyclops™ uses patented air classifier technology that enables efficient pulmonary delivery of epinephrine. The moderate-to-high inhaler resistance to airflow and efficient powder dispersion of the Cyclops™ reduces throat deposition and thereby the incidence of cough. The moderate-to-high resistance to airflow also narrows the bandwidth of achievable airflow rates through the Cyclops, thereby minimizing the chance of incorrect use.